NOT:ETR
Novartis AG
137,04 €
arrow_upward
+0,41%(+0,56) 1 p
21. okt, 17:35:53 GMT +2 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse NOT põhistatistika genereerimine…
Ava
136,56 €
Kõrge
137,28 €
Madal
136,02 €
Turu kapit.
312,48 mld
Keskm. maht
7,35 tuh
Maht
2,79 tuh
52 näd kõrgeim
144,12 €
52 näd madalaim
104,52 €
Töötajate arv
75 tuh
Ava
136,56 €
Kõrge
137,28 €
Madal
136,02 €
Turu kapit.
312,48 mld
Keskm. maht
7,35 tuh
Maht
2,79 tuh
52 näd kõrgeim
144,12 €
52 näd madalaim
104,52 €
Töötajate arv
75 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Yahoo Finance
·
2 tunni eest
Novartis (NVS) Grew Sales Again as Entresto Fell 50%, Can Remibrutinib Carry It?
Yahoo Finance
·
4 tunni eest
Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica (PMR)
AD HOC NEWS
·
5 tunni eest
Novartis stock: UBS keeps Hold rating and CHF 116.00 target for Novartis stock
AD HOC NEWS
·
12 tunni eest
Novartis stock has investor call on October 23 ahead of Xetra open
Profiil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Teave üksuse Novartis AG kohta
TegevjuhtVasant Narasimhan
Töötajad75,3 tuh
Asutatud7. märts 1996
PeakontoridBasel, Basel, Šveits
Sektor-
Veebisaitnovartis.com